Safety, Tolerability and Pharmacokinetics (PK) of Intravenous Zanamivir (IVZ) Treatment in Hospitalized Pediatric and Adolescent Patients with Influenza: A Phase II Open-Label, Multicenter, Single- Arm Study | Zendy

Jeffrey L. Blumer | Zendy; John S. Bradley | Zendy; José R. Romero | Zendy; Marian G. Michaels | Zendy; David W. Kimberlin | Zendy; Go Yamamoto | Zendy; Grace Roberts | Zendy; Mohammad Hossain | Zendy; Denise Shortino | Zendy; Phillip Yates | Zendy; Bryan Adams | Zendy; Amanda Peppercorn | Zendy

Open Access

Safety, Tolerability and Pharmacokinetics (PK) of Intravenous Zanamivir (IVZ) Treatment in Hospitalized Pediatric and Adolescent Patients with Influenza: A Phase II Open-Label, Multicenter, Single- Arm Study

Author(s) -

Jeffrey L. Blumer,

John S. Bradley,

José R. Romero,

Marian G. Michaels,

David W. Kimberlin,

Go Yamamoto,

Grace Roberts,

Mohammad Hossain,

Denise Shortino,

Phillip Yates,

Bryan Adams,

Amanda Peppercorn

Publication year - 2016

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofw194.26

Subject(s) - medicine , tolerability , pharmacokinetics , open label , zanamivir , open label study , neuraminidase inhibitor , phases of clinical research , adverse effect , pediatrics , pharmacology , covid-19 , clinical trial , infectious disease (medical specialty) , disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research